Funding Details
- Awarder
- Inbox
- Date Award
- February 05, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Traction
- Phase 1 results for MST-01 demonstrate rapid symptom relief.
- Company Description
- Miist Therapeutics is a physics-based developer of inhaled medicines that has clinically validated its approach and is advancing two assets: MST-01 for smoking addiction and MST-02 for migraine treatment.
- Market
- Inhaled medicines for smoking addiction and migraine treatment
- Location
-
Alameda,
California,
USA
- Coinvestors
- Refactor Capital, 1517 Fund, Freeflow Ventures, Entrepreneur First, California Innovation Fund
Links